Annual General Meeting 2021
The Annual General Meeting of Fresenius Medical Care AG & Co. KGaA took place on Thursday, May 20, 2021 as a virtual General meeting without the physical presence of shareholders or their proxies.
The documents and the further information to be made available pursuant to section 278 (3) AktG in connection with section 124a AktG as well as all other information pertaining to the General Meeting are available below.
Information pursuant to Table 8 of the Annex to the Implementing Regulation (EU) 2018/1212
Letter of the Chairman of the Supervisory Board Dr. Dieter Schenk
Information in accordance with Table 3 of the Annex to the Implementing Regulation (EU) 2018/1212)
Form for shareholders to authorize a proxy and to issue instructions (German only)
Information for holders of American Depositary Receipts
Annual Financial Statements 2020 according to HGB (German only)
Annual Report 2020 (including Consolidated Financial Statements according to IFRS and Non-financial Group Report)
Report by the Supervisory Board
Report of the General Partner pursuant to section 289a para. 1, section 315a para. 1 HGB
Sustainability Disclosures
We are committed to providing transparent and relevant sustainability information to our stakeholders. The tables below give a comprehensive overview of our sustainability performance:
Below you will find the countermotion from a shareholder within the meaning of Section 126 of the German Stock Corporation Act (Aktiengesetz) on item 4 of the agenda of the virtual Annual General Meeting of Fresenius Medical Care AG & Co. KGaA on May 20, 2021 and the position of the Management.
